Search inside Asthma
24/7 Customer Support
Brar participated in development efforts for asthma and topical Aristocort.
Its ketas product is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.
About MN-## (ibudilast) MN-## (ibudilast) has been marketed in Japan and Korea since 1989 to treat post-stroke complications and bronchial asthma.
Ibudilast has been used in asthma and post-stroke disorders in Japan for around ## years.